Investor Day 2024
Logotype for Oscar Health Inc

Oscar Health (OSCR) Investor Day 2024 summary

Event summary combining transcript, slides, and related documents.

Logotype for Oscar Health Inc

Investor Day 2024 summary

8 Jul, 2026

Vision and strategy

  • Introduced a dynamic three-year strategic plan, updated annually, focused on achieving at least 20% annual revenue growth and 5% operating margin by 2027, without relying on enhanced subsidies.

  • Mission centers on making a healthier life accessible and affordable for all, leveraging healthcare and technology expertise.

  • Four strategic objectives: achieve ~20% revenue CAGR and ~5% operating margin by 2027, enhance member experience, externalize technology, and expand the individual market with ICHRA.

  • Prioritizing near-term profitability, ACA footprint expansion, and leveraging technology to empower the broader healthcare system.

  • Compensation for leadership is tied to three-year EBIT targets to ensure alignment with strategic objectives.

Financial guidance and capital allocation

  • Reaffirmed 2024 guidance: $8.3B–$8.4B revenue, 20.5%–21.0% SG&A ratio, 80.2%–81.2% MLR, and $125M–$175M Adjusted EBITDA.

  • Long-term targets include 20% revenue CAGR and 5% operating margin by 2027, with EPS expected to exceed $2.25 per share.

  • Positioned for strong cash flow and capital generation, with ability to self-fund growth and future allocation priorities.

  • Fixed cost leverage, technology-driven efficiencies, and disciplined pricing are key to margin improvement.

  • Capital allocation will prioritize organic growth, with flexibility for optimization and potential share buybacks if excess capital persists.

Growth strategy and market expansion

  • Membership grew 150% since 2021, reaching ~1.5 million as of April 2024, and ACA market share increased from 4% to 7% across 18 states.

  • Growth pillars: disciplined footprint expansion, innovative products/experiences, and robust total cost of care management.

  • Plans to expand ACA reach from 50% to 70% by 2027, targeting entry into 150+ new MSAs, with further upside from ICHRA and potential subsidy extensions.

  • Existing markets expected to drive 50% of incremental growth, new markets 40%, and product innovation (including ICHRA) the remainder.

  • Product innovation includes culturally tailored offerings, chronic condition plans, and technology-enabled care journeys.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more